LY4257496
Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name LY4257496
Trade Name
Synonyms LY-4257496|LY 4257496
Drug Descriptions

Limited information is currently available on LY4257496, a putative radioligand therapy targeting GRPR (Aug 2025).

DrugClasses
CAS Registry Number NA
NCIT ID NA

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abemaciclib + LY4257496 Abemaciclib LY4257496 0 0
Capecitabine + LY4257496 Capecitabine LY4257496 0 0
Fulvestrant + LY4257496 Fulvestrant LY4257496 0 0
Imlunestrant + LY4257496 Imlunestrant LY4257496 0 0
LY4257496 LY4257496 0 0


Additional content available in Icon for CKB-BoostCKB BOOST